Lantheus inks purchasing deal with MDS Nordion for rare isotope
July 8, 2010 by MassDevice staff
Lantheus Medical Imaging Inc. arranges a new manufacturing and supply deal for molybdenum-99, the main ingredient for its imaging isotope generators.
Lantheus Medical Imaging Inc. sealed a new purchasing deal with Ottawa-based MDS Nordion for a rare imaging isotope, molybdenum-99.
The Billerica, Mass.-based medical imaging company will begin receiving a weekly supply of Mo-99 when the National Research Universal reactor in Chalk River, Ontario, goes back online, expected the end of July. The contract is good through July 2011.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
- How to simplify consents
- When conduct becomes a crime
Navigation
NEWS
Layoffs: IntriCon's undergoes "right-sizing" by firing 35 admin and support workers
Medical monitoring devices maker IntriCon says it's going to lay off 35 of its employees as part of a...
FDA OKs expanded trial for HeartWare's heart pump
The FDA grants conditional approval for another arm of HeartWare International's clinical trial of...
Theragenics gives PE firm Juniper another week of exclusivity in buyout bid
Georgia medical device maker Theragenics gives private equity firm Juniper Investment Co. an extra...
Survey: Most companies aren’t ready to implement healthcare reform | MassDevice.com On Call
56% of surveyed manufactures were unprepared for HC reform, and most cited rising costs as a top...
